PDL BioPharma Inc. (PDLI) 6.59 -0.01

Trade PDLI
NOW!
Last Trade:6.59Short Ratio:6.80
Last Trade Time:4:00pmDay Range:6.55 - 6.66
Ask:6.59Year Range:5.20 - 9.32
Bid:6.50One Year Target:7.67
Open:6.62Exchange:NasdaqNM
Volume:3432915EBITDA:298.4M
Prev. Close:6.60Market Cap:788.6M
50 Day Moving:6.7908Div Yield:25.30
200 day moving:7.4911PE:6.41

PDL BioPharma To Hold Annual Meeting of Stockholders on June 9, 2010

Posted on 03/16/10 at 8:39am
PDL BioPharma To Hold Annual Meeting of Stockholders on June 9, 2010 PR Newswire INCLINE VILLAGE, Nev., March 16
Click here to read the rest of the article

PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes

Posted on 03/15/10 at 8:36am
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes - Company Clarifies Facet Stock Distribution Value - PR Newswire INCLINE VILLAGE, Nev., March 15
Click here to read the rest of the article

Biotech Stocks Mixed (CYCC, INCY, CYTR, BPAX, ITMN, CTIC, PDLI, GNVC, AMLN, HGSI)

Posted on 03/12/10 at 4:00am
(EMAILWIRE.COM, March 12, 2010 ) Dallas, Tx - Following were among the Biotech companies whose shares were actively traded in Thursday 's session. Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) went up 6.44% to $2.81 on 5.16 million shares. The stock is up over 903% in the last one year of trading sessions.
Click here to read the rest of the article

Notable Healthcare Stocks (AMLN, PDLI, OCLS, HOLX)

Posted on 03/11/10 at 4:00am
(EMAILWIRE.COM, March 11, 2010 ) Dallas, Tx - Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) lost 4.40% to $19.98 on 3.26 million shares after the stock was initiated as Buy by Merriman. Subscribe to daily free stock newsletter by visiting: http://www.PennyStockPickReport.com
Click here to read the rest of the article

PDL BioPharma to Present at the Cowen and Company 30th Annual Health Care Conference on March 9, 2010

Posted on 03/03/10 at 9:45am
PDL BioPharma to Present at the Cowen and Company 30th Annual Health Care Conference on March 9, 2010 PR Newswire INCLINE VILLAGE, Nev., March 3
Click here to read the rest of the article

PDL BioPharma Misses Estimates, Offers Revenue Guidance Below Estimates (PDLI)

Posted on 03/02/10 at 5:36pm
3/2/2010-Shares of PDL BioPharma (NASDAQ: PDLI) are trading flat after hours Tuesday after the company reported Q4 EPS of $0.17, missing consensus estimates of $0.19. Revenues for the quarter fell 15% year-over-year to $58.3 million, falling short of consensus estimates of $70.3 million.
Click here to read the rest of the article

PDL BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results and Provides First Quarter 2010 Revenue Guidance

Posted on 03/02/10 at 5:06pm
PDL BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results and Provides First Quarter 2010 Revenue Guidance -Conference Call Today at 4:30 p.m. Eastern Time - PR Newswire INCLINE VILLAGE, Nev., March 2
Click here to read the rest of the article

PDL BioPharma to Announce Fourth Quarter and Full Year 2009 Financial Results and Hold Conference Call on March 2, 2010

Posted on 02/23/10 at 3:39am
PDL BioPharma to Announce Fourth Quarter and Full Year 2009 Financial Results and Hold Conference Call on March 2, 2010 PR Newswire INCLINE VILLAGE, Nev., Feb. 22
Click here to read the rest of the article

SmarTrend's Trend Spotter Sees Continued Downward Momentum on Shares of PDL BioPharma (PDLI)

Posted on 02/10/10 at 7:55pm
SmarTrend identified a Downtrend for PDL BioPharma (NASDAQ: PDLI) on November 27, 2009 at $6.71. In approximately 3 months, PDL BioPharma has returned 3.1% as of today's recent price of $6.50.
Click here to read the rest of the article

Top 5 Small-Cap NASDAQ Stocks with Lowest PEG Ratio (YONG, PDLI, HOGS, CMED, TRLG)

Posted on 02/10/10 at 4:47am
Below are the top 5 small-cap stocks on the NASDAQ in terms of PEG ratio. Yongye International Inc (NASDAQ: YONG) has a PEG ratio of 0.20. The return on assets for YONG is 30.36%.
Click here to read the rest of the article
Posted in